Baillie Gifford & Co, together with its wholly owned subsidiary Baillie Gifford Overseas Limited, now holds B shares in Novozymes A/S to a total of 15,498,025 shares of a nominal value of DKK 30,996,050, equivalent to 4.999% of Novozymes A/S’ share capital and 1.95% of the voting rights.
Major shareholder announcement
In accordance with section 29 of the Danish Securities Trading Act, Novozymes hereby announces that it has been informed that Baillie Gifford & Co, together with its wholly owned subsidiary Baillie Gifford Overseas Limited, has decreased its holding of B shares in Novozymes to 4.999%, previously reported at 5.04% in company announcement no. 16, April 2016.
| Source: Novozymes A/S
Attachments
